Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Clin Pharmacol. 2015 Mar 30;55(7):798–808. doi: 10.1002/jcph.481

Figure 1.

Figure 1

Figure 1

Mean and standard deviation (A) plasma and (B) genital viral loads at each study day for women taking atazanavir (ATV) or efavirenz (EFV) plus tenofovir and emtricitabine. The dashed horizontal line in each plot indicates the limit of detection.